International Regulators Address Questions On Leveraging Each Other’s Decisions
Executive Summary
Initiatives from regulators around the world seek to promote regulatory reliance at global level.
You may also be interested in...
How The ACCESS Consortium’s New ‘Promise Pathway’ Can Benefit Drugmakers
Pharmaceutical companies that develop new medicines for life-threatening or severely debilitating conditions could be eligible to file for a priority review in the five ACCESS Consortium member countries under a new pilot scheme.
International Regulators Say Collaboration Is Key To Tackling Pharma Globalization Challenges
Regulators from Canada, the UK and Australia discuss their experiences of working together under both the ACCESS Consortium, an international regulatory worksharing coalition, and Project Orbis, a parallel review process designed to speed up access to oncology medicines.
Regulatory Reliance Key To Cancer Drug Access in Lower-Income Countries
Regulatory reliance will be vital in improving access to oncology medicines in low- and lower-middle income countries, delegates at a recent regulatory conference were told.